News

print


Product News and Articles

41 - 50 of 142 Articles Previous 5 6 7 Next Next

09-May-2013

Bio-Rad Introduces New PrimePCR™ Mouse Assays and Panels — Industry’s Only Lab-Validated Real-Time PCR Primers

Bio-Rad’s PrimePCR assays for quantitative real-time PCR (qPCR), the industry’s only real-time PCR primers experimentally validated to ensure performance, have been expanded to include assays and panels for the mouse genome.
More »

06-May-2013

Bio-Rad Science Ambassador Program Reaches Students in Canada

As anticipated, scientists and teachers in Canada are sharing their passion for science and getting involved in the Bio-Rad Science Ambassador Program. Started in the US, the program matches life science teachers with scientist volunteers and provides free supplies for a fun and educational classroom activity.
More »

02-May-2013

PLOS ONE Study: Droplet Digital™ PCR Works for GMO Quantification

A new study demonstrates that Droplet Digital PCR (ddPCR™) technology is suitable for routine analysis of genetically modified organisms (GMOs) in food, feed, and seeds. The ddPCR assay is more accurate and reliable than real-time quantitative PCR (qPCR) for quantifying GMOs, especially at low levels.
More »

09-April-2013

Droplet Digital™ PCR Improves Detection Sensitivity of Telomerase Activity Assay

Droplet Digital PCR (ddPCR™) technology dramatically enhances current telomerase activity assays, with important implications for the early detection of cancer and the rapid evaluation of cancer therapeutics.
More »

12-March-2013

Bio-Rad Receives Frost & Sullivan 2012 North American Laboratory Researchers’ Choice: Future Market Leader of Digital PCR Technology Award

The QX100™ Droplet Digital™ PCR system was cited as the future market leader in digital PCR systems for its precision, simple workflow, and affordability. More than half of the researchers surveyed plan to buy a QX100 system in the next year
More »

09-March-2013

Bio-Rad Introduces New Bio-Plex Pro™ RBM Kidney Toxicity Panels

Bio-Plex Pro RBM human, rat, and canine kidney toxicity panels, developed in partnership with Myriad RBM, Inc., enable earlier quantitation of FDA-approved markers of acute and chronic kidney injury in clinical and preclinical settings with unprecedented sensitivity.
More »

20-February-2013

Bio-Rad Has Acquired AbD Serotec

Bio-Rad has completed the acquisition of AbD Serotec, a leading antibody manufacturer offering over 15,000 antibodies, kits, and accessories. This acquisition will accelerate future antibody development and enhance product offerings in diagnostics and life science research.
More »

07-February-2013

Bio-Rad Science Ambassador Program Provides Students Memorable Experience

As part of the recently-launched Bio-Rad Science Ambassador Program, students in the sixth and seventh grade at Jefferson Middle School conducted the Genes in a Bottle™ experiment under the guidance of Science Ambassador, Dr. Lisa Eccles.
More »

28-January-2013

Bio-Rad’s New Workflow Enables Highly Sensitive Evaluation of Antibodies Used to Measure HCP Impurities in Biotherapeutics

Bio-Rad will present a new and improved workflow for the evaluation of antibodies used to measure residual host cell protein impurities in biotherapeutics at the Well Characterized Biotechnology Pharmaceutical Symposium in Washington, D.C. January 29–31.
More »

04-January-2013

Digital PCR Pioneer Chooses Bio-Rad's QX100™ Droplet Digital™ PCR System to Develop Leukemia Test

Professor Alec Morley (Flinders University, Australia), a pioneer in digital PCR, has chosen Bio-Rad Laboratories’ QX100 Droplet Digital PCR system to develop a diagnostic test for chronic myeloid leukemia (CML). Monoquant, the company started by Morley to develop this technology, is seeking FDA approval for its new test.
More »

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.